Patient Identification Hurdles Sink English HTA For Roche’s Tumor-Agnostic Rozlytrek

 
• By Eliza Slawther
  
Blue figurine
Few people were identified as being eligible for treatment with Rozlytrek (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography